- Latest available (Revised)
- Original (As made)
The Medicines for Human Use (Prescribing)(Miscellaneous Amendments) Order 2009
You are here:
- UK Statutory Instruments
- 2009 No. 1165
- Explanatory Note
What Version
Opening Options
More Resources
Status:
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
EXPLANATORY NOTE
(This note is not part of the Order)
This Order makes amendments to—
(a)the Prescription Only Medicines (Human Use) Order 1997 (“the POM Order”) which specifies the description and classes of medicines (“prescription only medicines”) which may be sold or supplied only in accordance with the prescription of an “appropriate practitioner” and may be administered only by or in accordance with the directions of such a practitioner; and
(b)the Medicines (Pharmacy and General Sale—Exemption) Order 1980 (“the Pharmacy and General Sale Order”) which provides for exemptions from sections 52 and 53 of the Medicines Act 1968 (restrictions on the sale or supply of medicinal products).
Article 2 amends the POM order to remove an obsolete definition.
Article 3 amends the POM Order to enable a pharmacist to make an emergency sale or supply of a prescription only medicine at the request of a dentist who is unable to furnish a prescription immediately and to make an emergency sale or supply of a quantity of a prescription only medicine, except in the case of certain controlled drugs, sufficient to provide up to 30 days’ treatment to a person requesting the pharmacist to supply in the absence of a prescription from certain appropriate practitioners. It also amends the POM Order so that in the event of, or anticipation of, a pandemic disease which poses a serious threat to human health, a pharmacist need only satisfy himself that the person who is to be treated with a prescription only medicine has been prescribed that medicine before and that the dosage of that medicine is appropriate for that person.
Articles 4 and 5 amend the POM Order and Pharmacy and General Sale Order respectively to provide for the supply of a medicinal product during a pandemic in accordance with a protocol approved by the Secretary of State and Minister for Health, Social Services and Public Safety, or by an NHS body for the purpose of treating a pandemic disease which is a serious risk to human health or potentially a serious risk to human health.
An Impact Assessment has been prepared in respect of this Order which is available from the Medicines and Healthcare products Regulatory Agency, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.
Options/Help
Print Options
PrintThe Whole Instrument
PrintThis Explanatory Note only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Impact Assessments
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
- Why the government is proposing to intervene;
- The main options the government is considering, and which one is preferred;
- How and to what extent new policies may impact on them; and,
- The estimated costs and benefits of proposed measures.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.